Otezla (Apremilast)

Otezla reduces inflammation by its active ingredient apremilast’.  Otezla is a phosphodiesterase 4 inhibitor, reducing the activity of this specific enzyme thus controlling inflammation.

Otezla is used to treat psoriatic arthritis and moderate to severe chronic plaque psoriasis.  There is no cure for these conditions, however Otezla can control the symptoms.

Otezla is taken twice daily, beginning with a lower dose and increasing your dose to the most effective levels, usually 30mg twice per day.